Cutaneous human papillomavirus E6 impairs the cGAS-STING pathway

Emily Tolbert1, Dalton Dacus1, Rose Pollina1

  • 1Division of Biology, Kansas State University, Manhattan, KS 66506, USA.

Insights

Beta genus human papillomaviruses (β-HPVs) impair the cGAS-STING immune pathway. This allows β-HPV 8 E6 to promote skin cancer cell proliferation by evading innate immune responses to genomic instability.

Area of Science:

  • Virology
  • Immunology
  • Oncology

Background:

  • Beta genus human papillomaviruses (β-HPVs) are double-stranded DNA viruses linked to skin cancer.
  • β-HPV E6 expression increases micronuclei, which typically trigger innate immune responses.
  • β-HPV 8 E6 paradoxically promotes proliferation instead of cell elimination.

Purpose of the Study:

  • To investigate the mechanism by which β-HPV 8 E6 promotes proliferation despite inducing micronuclei.
  • To test the hypothesis that β-HPV 8 E6 attenuates the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway.

Main Methods:

  • Stimulation of cells with pLVX-GFP plasmid.
  • Immunoblot experiments to assess cGAS-STING pathway activation.
  • RNA-sequencing to analyze innate immune gene expression.
  • Microscopy to observe cGAS recruitment to micronuclei.

Main Results:

  • β-HPV 8 E6 reduced the magnitude and intensity of cGAS-STING pathway activation.
  • Impairment of the cGAS-STING pathway was most significant downstream of STING phosphorylation.
  • RNA-sequencing indicated downregulation of other innate immune pathways by β-HPV 8 E6.
  • cGAS was observed to be recruited to β-HPV 8 E6-induced micronuclei.

Conclusions:

  • β-HPV 8 E6 attenuates the cGAS-STING innate immune response, allowing proliferation of genome-destabilized cells.
  • This immune evasion mechanism may contribute to the prevalence of β-HPV infections.
  • Understanding this interaction is crucial for developing strategies against β-HPV-associated skin cancers.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K